Skip to main content
Earnings Labs
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) Earnings Dates & History

NASDAQ·Healthcare·Biotechnology

$12.17

+2.53%

Mkt Cap $840.14M

EPS — Estimate vs Actual

Quarterly History

Quarters are fiscal periods. Fiscal year ends in May.

Q4 2025

May 7, 2026

$92.06M$72.45M-21.30%$0.05-$0.07-240.00%
Q1 2026

Mar 12, 2026

$111.76M$106.50M-4.71%$0.15$0.07-53.33%
Q4 2025

Nov 6, 2025

$98.22M$97.29M-0.95%$0.05$0.10+100.00%
Q3 2025

Jul 31, 2025

$80.18M$110.56M+37.89%-$0.10$0.06+160.00%
Q2 2025

May 8, 2025

$72.73M$86.71M+19.22%-$0.25-$0.22+12.00%
Q1 2025

Mar 13, 2025

$60.93M$95.96M+57.50%$0.07$0.05-28.57%
Q4 2024

Oct 24, 2024

$75.58M$83.84M+10.93%$0.01-$0.02-300.00%
Q3 2024

Aug 1, 2024

$71.94M$79.60M+10.66%-$0.00-$0.01-400.00%
Q2 2024

May 8, 2024

$68.42M$90.03M+31.58%$0.01-$0.19-2000.00%
Q1 2024

Mar 14, 2024

$71.83M$59.71M-16.86%$0.05-$0.03-160.00%
Q4 2023

Oct 26, 2023

$61.67M$70.32M+14.02%$0.13$0.05-61.54%
Q3 2023

Aug 3, 2023

$53.23M$59.89M+12.51%-$0.02$0.02+200.00%
Q2 2023

May 11, 2023

$50.34M$58.84M+16.87%-$0.01-$0.17-1600.00%
Q1 2023

Mar 16, 2023

$60.25M$46.25M-23.24%$0.01-$0.19-2000.00%
Q4 2022

Oct 27, 2022

$53.50M$52.97M-1.00%$0.02$0.01-48.65%
Q3 2022

Aug 4, 2022

$51.99M$52.45M+0.89%$0.01$0.04+300.00%
Q2 2022

May 12, 2022

$47.65M$51.86M+8.85%-$0.06$0.05+183.33%
Q1 2022

Mar 17, 2022

$57.58M$51.56M-10.45%$0.01$0.01+0.00%
Q3 2021

Aug 9, 2021

—$58.33M——-$0.00—
Q2 2021

Apr 7, 2021

—$86.13M——$0.02—
Q1 2021

Mar 31, 2021

—$49.70M——$0.01—
Q3 2020

Sep 30, 2020

—$68.71M——$0.01—
Q2 2020

Jun 30, 2020

—$50.94M——$0.02—
Q1 2020

Mar 31, 2020

—$59.16M——$0.01—
Q4 2019

Dec 31, 2019

—$61.69M——$0.02—
Q3 2019

Sep 30, 2019

—$50.82M——$0.01—
Q2 2019

Jun 30, 2019

—$55.70M——$0.01—
Q1 2019

Mar 31, 2019

—$44.43M——$0.01—
Q4 2018

Dec 31, 2018

—$48.24M——$0.02—
Q3 2018

Sep 30, 2018

—$53.01M——$0.01—
Q2 2018

Jun 30, 2018

—$37.60M——$0.01—
Q1 2018

Mar 31, 2018

—$44.79M——$0.01—
Q4 2017

Dec 31, 2017

—$48.00M——-$0.09—
Q3 2017

Sep 30, 2017

—$37.15M——-$0.02—
Q2 2017

Jun 30, 2017

—$21.12M——-$0.05—
Q1 2017

Mar 31, 2017

—$17.69M——-$0.01—
Q4 2016

Dec 31, 2016

—$7.28M——-$0.01—
Q3 2016

Sep 30, 2016

—$4.36M——-$0.01—
Q2 2016

Jun 30, 2016

—$3.73M——-$0.01—
Q1 2016

Mar 31, 2016

—$2.85M——-$0.01—
Q4 2015

Dec 31, 2015

—$2.50M——-$0.01—
Q3 2015

Sep 30, 2015

—$4.12M——-$0.01—
Q2 2015

Jun 30, 2015

—$4.37M——-$0.01—
Q1 2015

Mar 31, 2015

—$2.09M——-$0.00—
Q4 2014

Dec 31, 2014

—$27.11M——$0.04—
Q3 2014

Sep 30, 2014

—$1.78M——$0.01—
Q2 2014

Jun 30, 2014

—$2.06M——-$0.02—
Q1 2014

Mar 31, 2014

—$2.68M——-$0.06—
Q4 2013

Dec 31, 2013

—$1.86M——-$0.02—
Q3 2013

Sep 30, 2013

—$2.27M——-$0.02—
Q2 2013

Jun 30, 2013

—$7.51M——-$0.02—
Q1 2013

Mar 31, 2013

—$794.78K——-$0.06—
Q4 2012

Dec 31, 2012

—$14.38M——-$0.01—
Q3 2012

Sep 30, 2012

—$842.07K——-$0.09—
Q2 2012

Jun 30, 2012

—$1.33M——-$0.23—
Q1 2012

Mar 31, 2012

—$1.56M——-$0.17—
Q4 2011

Dec 31, 2011

—$1.26M——-$0.08—
Q3 2011

Sep 30, 2011

—$1.37M——-$0.13—
Q2 2011

Jun 30, 2011

—$1.45M——-$0.17—
Q1 2011

Mar 31, 2011

—$1.27M——-$0.13—
Q4 2010

Dec 31, 2010

—-$200.30K——-$0.87—
Q3 2010

Sep 30, 2010

—$493.15K——-$0.29—
Q2 2010

Jun 30, 2010

—$268.09K——-$1.52—
Q1 2010

Mar 31, 2010

—$375.09K——-$0.72—
Q4 2009

Dec 31, 2009

—$1.14M——-$1.21—
Q3 2009

Sep 30, 2009

—$391.16K——-$1.19—
Q2 2009

Jun 30, 2009

—$490.91K——-$1.46—
Q1 2009

Mar 31, 2009

—$184.76K——-$0.89—